1 Ferguson DW.Digltalis and neurohormonal abnormalities in heart failure and implications for the rapy.Am J Cardiol, 1992, 69:24G
2 Van Veldhuisen DJ, Man in't Veld AJ, Dunselman PHJM, et al.Double-blind, placecontrolled study of ibopamine and digo xin in patients with mild to moderate heart failure:Results of the Dutch Ibopamine Multicenter Trial (DIM T).J Am Coll Cardiol, 1993, 22:1564
3 Lloyd MA, Sandberg SM, Edwards BS.Role of renal Na⁺-K⁺-ATP ase in the regulation of sodium excretion under normal conditions and in a cute congestive heart failure.Circulation, 1992,85:1912
4 Krum H, Bigger JT, Goldsmith RL, et al.Effect of long-term digo xin The rapy on autonomic function in patients with chronic heart failure.J Am Coll Cardiol, 1995, 25:289
5 Brouwer J, Van Veldhuisen DJ, Man in't Veld AJ, et al.heart rate variability in patients with mild to moderate heart failure:effects of neurohumoral modulation by digoxin and ibopamine.J Am Coll Cardiol, 1995, 26:9 83
6 Cohen JN.Management of chronic heart failure.N Engl J Med, 1996, 335:490
7 Uretsky BF.Digoxin in the treatment of patients with chronic heart failure.its place in therapy.drugs Aging, 1995, 7:1
8 Uretsky BF, Young JB, Shahidi FE, et al.On behalf of the PROVED investigative Group.Multicenter, double blind, placebo controlled randomized withrawal trial of the efficacy and safety of digoxin in patients with mild to mode rate chronic heart failure not treated with converting enzyme inhibitors.J Am Coll Cardiol, 1993, 22:9 55
9 Packer M, Gheorghiade M, Young JB, et al.Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-conver ting-enzyme inhibitors. N Engl J Med, 1993, 329:1
10 Fleg JH, Rothfeld B, Gottlieb SH, et al.effects of main taince digoxin on aerobic performance and exercise left vent ricular function in mild to mode rater heart failure due to coronary artery disease:a randomixxed, placebo-controlled, crossover trial.J Am Coll Cardiol, 1991, 17: 743
11 Kelly RA, Smith TW.Digoxin in heart failure:implications of recent trials.J Am Coll Cardiol, 1993, 22: Suppl A:107A
12 Gheorghiade M, Zarowitz BJ.Review of randomized trials of digoxin the rapy in patients with chronic heart failure.Am J Cardiol, 1992,69:48G
13 Van Veldhuisen DJ, Brouwer J, Man it't Veld AJ, et al.Progression of mild untreated heart failure during 6 months follow-up and clinical and neurohumoral effects of ibopamine and digoxin a s monThe rapy.Am J Cardiol, 1995, 75:7 96
14 Just H, Drexier H, Taylor SH, et al.for the CADS Study Group.Captopril versus digoxin in patients with coronary artery disease and mild heart failure.A Prospective, double-blind, placebo-controlled multicenter study.Herz, 1993,18(Suppl 1):436
15 Kleber FX, Thyroff-Frie singer U.Ibopamine versus digoxin in the treatment of mild congestive heart failure.Cardiology, 1990, 77(Suppl 5):75
16 BologesiR, Cucchini F, Javernaro A, et al.effects of acute K-strophantidin administration on left ventricular relaxation and filling phase in coronary artery disease. Am J Cardiol, 1992, 69:1 69
17 Eichhorn EJ, Alvarex LG, willard JE, et al.Digitalis improves my ocardial relaxation in patients with heart failure.(Abstr.)J Am Coll Cardiol, 1992, 19:2 54A
18 Bonaduce D, Petre tta M, Arrichiello P, et al.Effects of captopril treatment on left ventricular remode ling and function a fter anterior my ocardial infarction:comparsion with digitalis.J Am Coll Cardiol, 1992,19:858
19 Kober L, Torp-Pedersen C, Gasdsboll N, et al.Is digoxin an independent risk factor for long-term mortality after a cute my ocardial inf arction? Eur heart J, 1994, 15:382
20 Mancini DM, Benotti JR, Elkayam U, et al.and the PROM ISE Investigatiors and Coordinators.Antiarrhy thmic drug use and high serum levels of digoxin are idependent adverse prognostic factors in patients with chronic heart failure (abstract).Circulation, 1991, 84 (Suppl Ⅱ):11
21 Packer M.The development of positive inotropic agents for chronic heart failure:how have we gone astray ? J Am Coll Cardiol, 1993,22 (Suppl A):119A
22 Gheorghiade M, Hall V B, Jacobson G, et al.Effects of increasing maintainance dose of digoxin on left ventricular function and neurohormones in patients with chronic heart failure treated with diuretics and angio tensin-converting enzyme inhibitors.Circulation, 1995, 92:1 801
23 Cohn Jn, Johnson G, Ziesche S, et al.A Comparison of enalapril with hydralazine-isosrbide dinitrate in The treatment of chronic congestive heart failure.N Eng1 J Med, 1991,325:3 03
24 The SOLVD Investigators.effect of enalapril on survival in patients with reduced left ventriculare jection fractions and congestive heart failure.N Engl J Med, 1991, 325:293
25 Baker DW, Konstam MA, Bottorff M, et al. Management of heart failure.I.Pharmacologic treatment.JAMA, 1994, 272:1361

[1]	XU Jianfei, LIN Li. Research progress in pharmacological and non-pharmacological treatments of hypertension [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(4): 433-441.
[2]	ZHANG Hong-xia, WU Yong-jie, GAO Ming-tang. Protective effects of DDPH on myocardial ischemia reperfusion injury in isolated rat hearts [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(2): 160-165.
[3]	ZHU Shen-yin, ZHOU Yuan-da, DU Guan-hua. Research progress of xanthine oxidoreductase in biological functions and its inhibitor development [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(10): 1081-1086.
[4]	XUE Hao, GAO Min, LIU Guo-shu, WANG Hai. Effect of iptakalim hydrochloride on extracellular matrix of kidney in spontaneously hypertensive rats [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(10): 1122-1128.
[5]	YU Shuang, YU Li-mei, YUAN Mu, YU Hong, WU Qin, SHI Jin-shan. Effect of naftopidil'ramification-BWYJ on benign prostatic hyperplasia in mice and rats [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(8): 873-877.
[6]	QIAO Hai-ling, TIAN Xin, GUO Yu-zhong, ZHANG Li-rong, JIA Lin-jing, GAO Na, XIE Min. Study of relative bioavailability of chlorpheniramine maleate tablets in healthy volunteers [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(12): 1416-1419.
[7]	HE Ying-chun, ZHENG Qing-shan. Clinical trial design of compound lisinopril in treatment essential hypertension in Chinese patients [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(12): 1427-1429.
[8]	WANG Fang, WANG Li, HUA Lu, HU Yin, KANG Jian, ZHANG Yin-feng, LI Yi-shi. Effects of different dosage of amiodarone on heart rate and rhythm in healthy volunteers [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(7): 760-763.
[9]	WANG Hui-jiu, HUANG Xie-nan, JIANG Qing-song, WU Qin, SUN An-sheng, SHI Jing-shan. Effects of Naftopidil’ ramification-BWYJ on intracellularlar free Ca²⁺ in smooth cells [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(7): 772-775.
[10]	AN Wei, YANG Jing, ZHANG Jian-zhong, WANG Jun-jun, LIU Mao-nan. Protective effects of PL compound on experimental arrhythmias [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(7): 776-780.
[11]	GAO Min, WANG Yu, WANG Hai. Relaxation selectivity of three structurally diverse ATP-sensitive potassium channel openers, iptakalim, pinacidil and diazoxide on non-vascular smooth muscles [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(6): 633-636.
[12]	ZHANG Hui-jie, PENG Xiao-lin, WANG Qian-zhou, GONG Shang-chu. Study on serum concentration and effects of sotalol in treatment of patients with arrhythmia [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(5): 562-566.
[13]	DAI Chang-rong, LUO Lai-yuan. Effects of berberine on left atria and trachea in guinea pigs [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(5): 567-569.
[14]	ZHOU Si-xi. Analysis of utilization of antihypertensive drugs [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(4): 466-470.
[15]	LIU Chang-li, ZENG Fan-dian. Antioxidative and lipid-lowering effects of phenolic alkaloids of Menispermum dauricum [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(3): 343-347.

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments